跳至主要内容
临床试验/NL-OMON33407
NL-OMON33407已完成不适用

The role of intestinal integrity and inflammation in the pathogenesis of insulin resistance and non-alcoholic steatohepatitis in morbid obesity. - Intestinal permeability in diabetes type 2 and fatty liver disease

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 190 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
190

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Researchpopulation:
  • BMI >40 or BMI>35 kg/m2 with co-morbidities
  • planned for bariatric surgery
  • Age 18-60 years (to prevent inclusion of patients who are unable to give informed consent and to have inclusion criteria adjusted to the criteria for surgical intervention)
  • Control population:
  • BMI 20-25
  • planned for Nissen fundoplication or cholecystectomy
  • Age 18-60 years old

排除标准

  • For all patients:
  • Age <18 or >60 years
  • Diabetes Mellitus type I
  • Inflammatory diseases such as auto-immune diseases (due to a higher inflammatory profile)
  • Degenerative disase
  • Alcohol or drug abuse
  • use of corticosteroids and / or prednisolone (confounding effect on inflammatory status)

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验